IP Library Patent Application 13826217
Patent Application
App. No. 13/826,217

Dual Variable Region Antibody-Like Binding Proteins Having Cross-Over Binding Region Orientation

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
13/826,217
Abstract

The invention provides antibody-like binding proteins comprising four polypeptide chains that form four antigen binding sites, wherein each pair of polypeptides forming an antibody-like binding protein possesses dual variable domains having a cross-over orientation. The invention also provides methods for making such antigen-like binding proteins.

Claims (40)

1 - 40 . (canceled)

41 : A method of making an antibody-like binding protein comprising four polypeptide chains that form four antigen binding sites, comprising:

(a) identifying a first antibody variable domain that binds a first target antigen and a second antibody variable domain that binds a second target antigen, each containing a V L , and a V H ;

(b) assigning either the light chain or the heavy chain as template chain;

(c) assigning the V L of the first antibody variable domain or the second antibody variable domain as V L1 ;

(d) assigning a V L2 , a V H1 , and a V H2 according to formulas [I] and [II] below:

V L1 -L 1 -V L2 -L 2 -C L   [I]

V H2 -L 3 -V H1 -L 4 -C H1 -Fc  [II]

(e) determining maximum and minimum lengths for L 1 , L 2 , L 3 , and L 4 ;

(f) generating polypeptide structures of formulas I and II;

(g) selecting polypeptide structures of formulas I and II that bind the first target antigen and the second target antigen when combined to form the antibody-like binding protein; wherein:

V L1 is a first immunoglobulin light chain variable domain;

V L2 is a second immunoglobulin light chain variable domain;

V H1 is a first immunoglobulin heavy chain variable domain;

V H2 is a second immunoglobulin heavy chain variable domain;

C L is an immunoglobulin light chain constant domain;

C H1 is the immunoglobulin C H1 heavy chain constant domain;

Fc is the immunoglobulin hinge region and C H2 , C H3 immunoglobulin heavy chain constant domains; and

L 1 , L 2 , L 3 , and L 4 are amino acid linkers;

and wherein the polypeptides of formula I and the polypeptides of formula II form a cross-over light chain-heavy chain pair.

42 : The method of claim 41 , wherein the first antibody variable domain and the second antibody variable domain are the same.

43 : A method of making an antibody-like binding protein comprising four polypeptide chains that form four antigen binding sites, comprising:

(a) identifying a first antibody variable domain that binds a first target antigen and a second antibody variable domain that binds a second target antigen, each containing a V L , and a V H ;

(b) assigning either the light chain or the heavy chain as template chain;

(c) assigning the V L of the first antibody variable domain or the second antibody variable domain as V L1 ;

(d) assigning a V L2 , a V H1 , and a V H2 according to formulas [I] and [II] below:

V L1 -L 1 -V L2 -L 2 -C L   [I]

V H2 -L 3 -V H1 -L 4 -C H1   [II]

(e) determining maximum and minimum lengths for L 1 , L 2 , L 3 , and L 4 ;

(f) generating polypeptide structures of formulas I and II;

(g) selecting polypeptide structures of formulas I and II that bind the first target antigen and the second target antigen when combined to form the antibody-like binding protein; wherein:

V L1 is a first immunoglobulin light chain variable domain;

V L2 is a second immunoglobulin light chain variable domain;

V H1 is a first immunoglobulin heavy chain variable domain;

V H2 is a second immunoglobulin heavy chain variable domain;

C L is an immunoglobulin light chain constant domain;

C H1 is the immunoglobulin C H1 heavy chain constant domain; and

L 1 , L 2 , L 3 , and L 4 are amino acid linkers;

and wherein the polypeptides of formula I and the polypeptides of formula II form a cross-over light chain-heavy chain pair.

44 : The method of claim 43 , wherein the first antibody variable domain and the second antibody variable domain are the same.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 9, 2013
From: BAURIN, NICOLAS; BEIL, CHRISTIAN; CORVEY, CARSTEN; LANGE, CHRISTIAN; LI, DANXI; MIKOL, VINCENT; STEINMETZ, ANKE; RAO, ERCOLE
To: SANOFI
Reel/Frame 030757/0858 →